RENAL EFFECTS OF THE NITRIC-OXIDE SYNTHASE INHIBITOR, L-NG-NITROARGINE, IN DOGS

被引：28

作者：

YUKIMURA, T

YAMASHITA, Y

MIURA, K

OKUMURA, M

YAMANAKA, S

YAMAMOTO, K

机构：

[1] Department of Pharmacology, Osaka City University Medical School, Osaka, 545, Asahimachi 1-4-54, Abeno-ku

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1992年 / 5卷 / 07期

关键词：

ANTIDIURESIS; ANTINATRIURESIS; L-NG-NITROARGININE; RENAL BLOOD FLOW; VASOCONSTRICTION; GLOMERULAR FILTRATION RATE;

D O I：

10.1093/ajh/5.7.484

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

L-N(G)-Nitroarginine (LNNA), an analog of L-arginine, was infused into the renal artery of anesthetized dogs to assess the contribution of nitric oxide production in the regulation of renal hemodynamics and urine formation. Following intrarenal arterial infusion of LNNA (15-mu-g/kg/min) for 25 min, renal blood flow (RBF) gradually decreased and there was no reversion even 60 min after cessation of infusion, with no change in mean arterial blood pressure (MBP) and heart rate. Urine flow (UF) decreased while the glomerular filtration rate (GFR) did not change. The highest dose of LNNA (75-mu-g/kg/min) remarkably decreased RBF and increased MBP. The renal vasoconstriction and pressor responses induced by the highest dose of LNNA were significantly antagonized by an intravenous administration Of L-arginine (100 mg/kg/min). LNNA is characterized as a potent and long-lasting renal vasoconstrictor and decreases GFR, UF, and sodium excretion. It is suggested that nitric oxide produced in the kidney may have a significant role in the regulation of basal renal circulation and exert diuresis and natriuresis.

引用

页码：484 / 487

页数：4

共 21 条

[1] Furchgott R.F., Vanhoutte P.M., Endothelium-derived relaxing and contracting factors, FASEB J, 3, pp. 2007-2018, (1989)
[2] Palmer R.M.J., Ferrige A.G., Moncada S., Nitric oxide release acounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, pp. 524-526, (1987)
[3] Palmer R.M.J., Ashton D.S., Moncada S., Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, 33, pp. 664-666, (1988)
[4] Schmidt H.H.H.W., Klein M.M., Niroomand F., Bohme E., Is arginine a physiological precursor of endothelium derived nitric oxide, Eur J Pharmacol, 148, pp. 293-295, (1988)
[5] Gibson A., Mirzazadeh S., Hobbs A.J., Moore P.K., L-NG-Monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle, Br J Pharmacol, 99, pp. 602-606, (1990)
[6] Dubbin P.N., Zambetis M., Dusting G.J., Inhibition of endothelial nitric oxide biosynthesis by N-nitro-Larginine, Clin Exp Pharmacol Physiol, 17, pp. 281-286, (1990)
[7] Salom M.G., Lahera V., Romero J.C., Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine, Am J Physiol, 260, pp. F145-F149, (1991)
[8] Lahera V., Salom M.G., Fiksen-Olsen M.J., Romero J.C., Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin, Am J Hypertens, 4, pp. 260-262, (1991)
[9] Yamashita Y., Yukimura T., Miura K., Et al., Effects of NG-nitro-L-arginine on renal hemodynamic responses to endothelin-3 in anesthetized dogs, J Cardiovase Pharmacol, 17, pp. S332-S334, (1991)
[10] Rees D.D., Palmer R.M.J., Hodson H.F., Moncada S., A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation, Br J Pharmacol, 96, pp. 418-424, (1989)

← 1 2 3 →